You are here

  • Home
  • Archive
  • Volume 7, Issue 1
  • Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

Article metrics

Article menu

Download PDFPDF

XML
Research Article
Niclosamide, an antihelmintic drug, enhances efficacy of PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer

 

Online download statistics by month:

Online download statistics by month: January 2020 to June 2025

AbstractFullPdf
Jan 2020880
Feb 202018180
Mar 202046463
Apr 202018182
May 202044443
Jun 202038388
Jul 2020282810
Aug 2020313119
Sep 2020373727
Oct 2020525220
Nov 2020606024
Dec 2020575736
Jan 2021646431
Feb 2021545460
Mar 2021939353
Apr 202121821827
May 202110110121
Jun 2021808033
Jul 2021454531
Aug 2021393931
Sep 2021818250
Oct 2021707063
Nov 2021515143
Dec 2021888844
Jan 2022777833
Feb 2022909747
Mar 2022666631
Apr 2022768046
May 2022525725
Jun 2022596930
Jul 2022525416
Aug 2022576026
Sep 2022546027
Oct 2022616120
Nov 2022898925
Dec 2022676728
Jan 202310110123
Feb 2023687118
Mar 2023999927
Apr 202310010140
May 2023787913
Jun 2023757519
Jul 2023636322
Aug 2023656517
Sep 2023888920
Oct 2023858524
Nov 2023818114
Dec 2023838326
Jan 2024414218
Feb 2024575828
Mar 202410010079
Apr 2024889031
May 2024666621
Jun 2024515113
Jul 2024636530
Aug 2024555722
Sep 20246465143
Oct 2024686898
Nov 2024444522
Dec 2024586229
Jan 2025404025
Feb 2025545428
Mar 2025565737
Apr 2025747439
May 2025636427
Jun 2025383820
Total428743481966